key: cord-299333-qu0bmov5
authors: Reddy, Gireesh B.; Greif, Dylan N.; Rodriguez, Jose; Best, Thomas M.; Greditzer, Harry G.; Jose, Jean
title: Clinical Characteristics and Multisystem Imaging Findings of COVID-19: An Overview for Orthopedic Surgeons
date: 2020-08-17
journal: HSS J
DOI: 10.1007/s11420-020-09775-3
sha: 
doc_id: 299333
cord_uid: qu0bmov5

The COVID-19 pandemic holds widespread implications for global public health, economies, societies, and the practice of orthopedic surgery. As our knowledge of the transmissibility of SARS-CoV-2 and the symptomatology and management of COVID-19 expands, orthopedic surgeons must remain up to date on the latest medical evidence and surgical perspectives. While COVID-19 primarily manifests with pulmonary symptoms, cardiovascular, neurologic, and other major organ systems may also be affected and present with hallmark imaging findings. This article reviews initial and emerging literature on clinical characteristics and imaging findings of COVID-19. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11420-020-09775-3) contains supplementary material, which is available to authorized users.

Since December 2019, infections with severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), a novel betacoronavirus strain responsible for coronavirus disease 2019 (COVID- 19) , rapidly progressed from an isolated cluster of cases in the Hubei province of east central China to a pandemic, with significant global health and economic repercussions [4, 5, 10, 24, 25, 27, 28, 44, 58, 80, 91] . By mid-June 2020, the World Health Organization (WHO) had declared over 4.3 million people infected worldwide, with nearly 300,000 deaths. In the USA, despite unprecedented social distancing and public health measures, over 1.3 million people were infected, with more than 100,000 deaths [21] . Musculoskeletal chief complaints account for 18% of all healthcare visits in the USA [59] , with nearly 23 million orthopedic procedures performed annually worldwide, of which five orthopedic procedures comprise 17% of all operations in the USA [4] . Public safety restrictions on semi-elective and elective office visits and surgical procedures during the COVID-19 pandemic have created a tremendous backlog (estimated at more than 1 million cases in 2 years) for orthopedic practices and have taken many practices to a tenuous economic precipice [4, 39] .

As restrictions are eased nationally [1] , it is critical that orthopedic surgeons remain aware of the clinical and radiographic findings associated with COVID-19 to best evaluate surgical patients. In addition to the widely known pulmonary symptoms, COVID-19 patients may initially present with atypical neurologic, gastrointestinal, cardiac, and musculoskeletal imaging findings (Table 1) , which are more likely to be undiagnosed. We summarize the most recent literature describing the clinical and imaging findings in order to assist orthopedic surgeons in navigating a clinical and practice management landscape permanently transformed by the pandemic. 

The most common symptoms of patients presenting with COVID-19 are cough, dyspnea, and fever, while the most common reasons for admission are pneumonia and hypoxemia [12, 27, 36, 80, 91] . Approximately 14% of patients develop more severe symptoms, including acute hypoxic respiratory failure and acute respiratory distress syndrome (ARDS), while the mortality rate for patients requiring invasive mechanical ventilation is high (24.7% in New York City) [68, 81] . In a recent retrospective review of chest radiographic findings in 64 patients with COVID-19, Wong et al. reported consolidation (47%) and ground glass opacities (GGO) (33%) as the most common findings, usually in a peripheral (41%) or lower lobe (51%) distribution, with bilateral lung involvement in 50% ( Fig. 1 ) [72] . Pulmonary nodules, pleural effusions, lymphadenopathy, and lung cavitation (thick-walled abnormal gas-filled spaces within the lung) were usually absent [16] . Chest computed tomography (CT) is the gold imaging standard for diagnosing COVID- 19 . In a retrospective cohort study from Wuhan, including some of the earliest diagnosed patients, CT scans were reviewed sequentially from prior to symptom onset to 3 weeks after onset [72] . The authors found that even before symptom onset, CT scans demonstrated unilateral GGO that progressed to bilateral diffuse GGO, with or without consolidation [57, 72] .

Early reports from China described the most common imaging findings on CT as GGO (56.4%) and bilateral patchy shadowing (51.8%) [27] . In another recent review, Pan et al. correlated time course of lung changes on CT scans with COVID-19 disease progression [61] . In the "early stage" of the disease (0 to 4 days after onset of symptoms), GGOs in subpleural locations unilaterally or bilaterally were observed (Fig. 2) . During the "progressive stage" (days 5 to 8), CT scans demonstrated multilobe distribution of diffuse GGOs and crazy-paving pattern (GGOs with superimposed inter-and intralobular septal thickening), and consolidation was observed, without mediastinal lymphadenopathy ( Fig. 3) [70]. In the "peak stage" (9 to 13 days), consolidations became denser, with worsening diffuse GGOs, crazypaving, and residual parenchymal bands (Fig. 4) . If patients clinically improved, they entered the "absorption stage" (usually more than 14 days after symptom onset). In this stage, GGOs persisted, but the crazy-paving resolved, and consolidations improved. If the patient worsened, with increased oxygen requirements, need for more invasive ventilation, and other intensive care unit (ICU) care, a transition to a denser alveolar consolidation pattern on radiographic imaging was noted. At this point, acute respiratory distress syndrome was likely to occur, and a low clinical threshold was necessary for transfer to an ICU for advanced respiratory support [70] .

There is a characteristic change in imaging of the chest, not only temporally from symptom onset but also with increasing disease severity. In a retrospective study of 83 patients, patients with more severe manifestations of COVID-19 had higher thin section CT score, incidence of consolidation, mediastinal lymph node enlargement, septal thickening, pleural effusion, and pericardial effusion than those with less severe presentations [47, 77] . Salehi et al. reviewed the imaging findings of 919 patients and corroborated this progression of severity [70] . Other uncommon findings that occur later in the progression of COVID-19 may also include bronchiectasis, pleural thickening, enlargement of intralesional pulmonary vessels greater than 3 mm in diameter, cavitation, or CT halo signs (GGOs surrounding a pulmonary nodule or mass) [66, 70] . Finally, as mentioned, disease resolution is seen with the gradual disappearance Gastrointestinal manifestations CT and US abdomen (Figs. 13 and 14) • Small and large bowel wall thickening, due to gastroenteritis or ischemia • Bowel and mesenteric infarction and necrosis, with associated non-enhancing bowel, pneumatosis, portal venous gas, and bowel perforation • Portal vein thrombosis • Distended gallbladder containing sludge suggestive of cholestasis • Solid organ inflammation and infarction, including the pancreas (pancreatitis), liver (hepatitis), kidneys, and spleen

CT computed tomography MRI magnetic resonance imaging 1 . Chest X-ray findings of COVID-19 pneumonia: frontal radiograph of the chest demonstrates low lung volumes with bilateral perihilar ground glass opacities and peripheral airspace consolidations (blue arrows) in a predominately mid and lower lobe distribution.

of consolidative opacities and decreased number of lesions and/or involved lobes. A recent meta-analysis of 68 articles [42] found that chest CT has a sensitivity and specificity of 94% and 37%, respectively, in detecting COVID-19 [3, 22] . Imaging characteristics of COVID-19 are distinctive enough that Chinese and American radiologists were able to differentiate COVID-19 (n = 219) from respiratory viral pneumonia (n = 205) when presented with respective imaging [6] .

Early reports from Italy and China indicated that although pulmonary diseases including ARDS and diffuse pneumonia comprise the predominant lethal complications of COVID-19, patients have also presented with or developed significant cardiac signs and symptoms [50] . In one of the first series of COVID-19 patients from Wuhan, Huang et al. [36] found that five of 41 (12%) had some form of acute cardiac injury, determined either by elevated cardiac biomarkers above the 99th percentile or new abnormalities/arrhythmias on electrocardiography or echocardiography as seen in patients with myopericarditis ( Fig. 5 ) or myocardial infarction (Fig. 6) [73] . A case report from Italy described a COVID-19 patient without a CVD history who presented with electrocardiographic and biomarker changes indicative of acute cardiac injury [38] . Transthoracic echocardiography (TTE) and gadoliniumenhanced cardiac magnetic resonance imaging (Gd-cardiac MRI) demonstrated increased wall thickness, diffuse biventricular hypokinesis, severe left ventricular dysfunction, biventricular myocardial interstitial edema (on short-tau inversion and T2-mapping sequences), acute myocarditis, and pericardial effusion, especially around the right cardiac chambers.

The above suggests that COVID-19 may be related to cardiac injury of undetermined pathophysiology. Cardiac injury in the context of viral infections has been studied in the past. In a self-controlled case series involving 365 admissions in Ontario, Canada, laboratory-confirmed respiratory viral infections were associated with 6.05% increase in the incidence of acute myocardial infarction within 7 days of viral detection [45] . Viral respiratory tract infections may lead to complications such as acute coronary syndrome (ACS) or venothrombotic events (VTEs) secondary to immune system hyperactivation and generation of a thrombogenic state [18, 43] .

Global reports of COVID-19-associated coagulopathy with multifocal thromboembolic disease are rapidly growing and include pulmonary emboli, limb ischemia, and cerebral infarct; often associated with poorer prognosis [19, 51, 54, 75, 87, 88] . Several European studies have demonstrated higher rates of VTE in the COVID-19 population [32, 49] . In a study of 150 COVID-19 ICU patients, nearly 64 (43%) had a thrombotic event, including pulmonary embolism (Fig. 7) and continuous renal replacement therapy (CRRT) circuit clotting [32] . In a study of 48 COVID-19 ICU patients at two institutions, an alarming 85% were positive for DVTs, despite almost all being on prophylactic anticoagulation [67] . Another study of 26 ICU patients screened for DVTs using duplex ultrasonography found that 69% were positive, with 56% positive despite being on therapeutic anticoagulation [48] . Up to 30% of COVID-19 patients with pulmonary symptoms were diagnosed with acute pulmonary embolus on pulmonary CT angiogram over a 1month period in a tertiary care center and all with higher levels of D-dimer (2660 μg/L) and C-reactive protein (CRP) than usually encountered, suggesting an independent association between D-dimer level and disease severity [46, 65] . Antiphospholipid antibodies in the setting of multifocal cerebral infarct have also been observed in COVID-19 patients [88] . While noted in other infections, antiphospholipid antibodies have not been associated with thrombotic events in these circumstances [71, 88] .

COVID-19 musculoskeletal and neurologic manifestations are being reported with increased frequency, particularly in patients with more severe respiratory disease, indicating coronavirus neurotropism possibly directly related with higher viral loads, which are now detectable in cerebrospinal fluid [20] . Angiotensin-converting enzyme 2 (ACE-2) receptors may be responsible for COVID-19 cerebral involvement via entry through the cribriform plate [56] .

Reportedly, up to 84% of ICU COVID-19 patients demonstrate neurologic symptoms [31, 41] . Neuroimaging findings beyond those of acute infarction, hemorrhage, and vessel thrombosis include meningoencephalitis and acute necrotizing encephalopathy (ANE). There is mounting evidence of increased leptomeningeal enhancement, fluidattenuated inversion recovery (FLAIR) cortical signal abnormalities, cortical diffusion restriction, and cortical blooming artifact, suggesting either infectious, autoimmune, or critical illness-related encephalitis, hypoxia, hypoglycemia, and seizure [41] . In a limited series over a 2-week period in March 2020 at a single institution, five patients under the age of 50 years suffered large vessel arterial cerebral infarct (with preferential involvement of the middle cerebral artery), a dramatic increase compared with a pre-COVID-19 average of 0.79 strokes per 2 weeks in patients younger than 50 years (Fig. 8) [60] . In a study by Mao 36 .4% had neurologic symptoms, including acute ischemic stroke, intra-cranial hemorrhage ( Fig. 9 ), impaired consciousness, and skeletal muscle injury defined as pain with elevated serum creatinine kinase levels [53, 64] .

From Italy, of an estimated 1200 COVID-19 patients admitted over 1 month, five developed rapidly progressive Guillain-Barré syndrome (Fig. 10 ) that began with lower extremity paresis that progressed to flaccid tetraparesis and tetraplegia [76] . Mahammedi et al. reported that 108 of 725 (15%) consecutive hospitalized COVID-19 patients had neurologic symptoms requiring neuroimaging in Italy, and of those, 64 (59%) had altered mental status, and 34 (31%) had ischemic stroke; 47% of those patients had acute neuroimaging abnormalities that included acute ischemic stroke, intracranial hemorrhage (possibly due to cerebrovascular endothelial rupture), cerebral venous thrombosis, multiple sclerosis plaque exacerbation, encephalopathy, Guillain-Barré syndrome, Miller-Fisher Syndrome, and posterior reversible encephalopathy syndrome [7, 52] . In an observational study of 58 encephalopathic COVID-19 patients with ARDS, 38 had upper motor neuron signs, while eight of 13 who underwent MRI demonstrated leptomeningeal enhancement (Fig. 11 ), two of 13 had focal acute ischemic strokes, and 11 of 11 displayed frontotemporal hypoperfusion abnormalities on profusion studies [31] . Anosmia, possibly related to ACE-2 involvement, has also been reported [33] .

Limited reports of COVID-19 isolated musculoskeletal manifestations are currently available. Similar low incidence case series of critical illness myopathy or myositis (Fig. 12 ) [55] and critical illness polyneuropathy following Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS) have also been reported, at times with an association with concurrent myocarditis [9, 14, 74] . In all of these cases, patients typically present with myalgia and muscle weakness, with rhabdomyolysis and elevated creatine kinase (CK) levels representing more severe manifestations [27, 78, 86] . Elevated CK levels are associated with increased rates of mortality and interstitial pneumonia in COVID-19 patients [90] .

Evidence suggests that some patients with severe COVID-19 might have a cytokine storm syndrome, which can be seen by testing for serum cytokine levels [37] . Recently, ANE, a rare complication of viral infections related to intracranial cytokine storms that result in blood-brain barrier breakdown without direct viral invasion or demyelination, has been reported as a result of COVID-19 [65] . The most common findings of ANE include hypoattenuating lesions on CT and T2/FLAIR hyperintense lesions on MRI, in a bilateral symmetric multifocal distribution predominantly involving the thalami and to a lesser extent the brain stem, cerebral white matter, and cerebellum. In addition, findings of leukoencephalopathy, including CT hypoattenuation of the bilateral cerebral hemispheric white matter and corpus callosum, as well as MRI diffuse confluent white matter T2/ FLAIR hyperintensities, scattered micro-hemorrhage in the corpus callosum, and posterior circulation hyperperfusion without diffusion restriction or abnormal enhancement have been reported [69] . It is uncertain if COVID-19-related white matter injury findings are the result of ICU anesthesia-related toxicity, COVID-19-associated cytokine release syndrome, or COVID-19-related endotheliitis with thrombotic microangiopathy [69] .

Beyond neurologic manifestations, cytokine storm also has pulmonary manifestations, namely, pulmonary and interstitial damage caused by nonspecific inflammatory cell infiltration [83] . For COVID-19, in addition to the previously described radiographic findings, this syndrome may lead to the development of bilateral pneumonia or ARDS much faster in thus subgroup of patients, as well increased rates of ICU admission, mechanical ventilation, and subsequent mortality [83] .

Even without pulmonary or neurologic manifestations, cytokine storm can lead to multi-organ system failure, which explains reports of elevated liver enzymes, creatine, and other important markers in COVID-19 patients who do not present with the above manifestations [83] . This is due to the systemic exposure to large amounts of pro-inflammatory cytokines that leads to the immune system "attacking" the body, particularly interstitial and parenchymal spaces [17] . Vascular compromise due to extensive endothelial damage is also possible [79] .

Though not as severe, gastrointestinal symptoms have been reported in up to 20% of COVID-19 patients [15] . This may be due to the increased gastrointestinal wall permeability to viral pathogens, which promote malabsorption by infected enterocytes [26] . The most common symptoms include diarrhea, abdominal pain, or vomiting, though preliminary data suggests that patients with these symptoms tend to have an improved prognosis independent of patient age or sex [2] . Constipation, melena, and anorexia have also been reported but less commonly [34, 85] . More severe manifestations of gastroenteritis can be seen on CT scan and can be the only presenting symptom (Fig. 13) [30, 62] . Patients can have pertinent laboratory findings, namely, elevated lipase and/or alkaline phosphatase levels, which are associated with poor prognosis as they reflect a greater systemic inflammatory response [2] .

The most common abdominal imaging findings in COVID-19 ICU patients include small and large bowel wall thickening, non-enhancing bowel, pneumatosis, portal venous gas, and bowel perforation, all related to bowel and mesenteric ischemia, infarction, and necrosis ( Fig. 14) [11] . Portal vein thrombosis and distended gallbladder containing sludge suggestive of cholestasis have also been observed. In addition, evidence of inflammation and infarction in other solid organs, including the pancreas, liver, kidneys, and spleen, have been reported, particularly in ICU COVID-19 patients. Although the exact pathophysiology is uncertain, these findings are thought to be multifactorial in origin, resulting from a combination of direct SARS-CoV-2 infection and indirect systemic derangements associated with critical illness, including small vessel thrombosis related to ICU hypercoagulopathy and nonocclusive ischemia related to an ICU hyperinflammatory effect [11, 35] .

Though preliminary in nature, current findings may suggest that SARS-CoV-2 can be detectable in both hepatic tissue and cholangiocytes due to ACE-2 expression [13] . Elevated liver enzymes have been found in blood samples of COVID-19 patients, but it is important to note that elevated liver enzymes do not necessarily mean liver damage is present [23] . Imaging is currently not indicated for evaluation of hepatic pathology in COVID-19 patients, but hepatic steatosis and mild lobular and portal inflammation may be seen. Whether these are indeed due to COVID-19 or the consequence of drug-induced hepatic injury is still unknown [82] .

Recent studies suggest that COVID-19 may cause acute renal failure, as both podocytes and proximal convoluted tubular cells express certain genes (ACE-2 and transmembrane serine protease 2 [TMPRSS2]) that increase the host viability for SARS-CoV-2 [63] . The viral cytopathic effect on these cells has been linked as the cause of acute renal failure, which is secondary to ARDS as one of the more common fatal presentations in patients with COVID-19 [82] . Separately, a case report found that patients who developed rhabdomyolysis throughout the course of their disease are also at risk for acute renal failure, with manifestations of lower extremity pain and fatigue (separate from generalized myositis) followed by rising plasma creatine level [40] .

Renal imaging studies currently have little to no diagnostic role in COVID-19 patients, though one would theoretically expect to note increased parenchymal echogenicity via ultrasound [8] . In fact, it is more important to keep in mind that while COVID-19 patients primarily present with respiratory findings, acute renal injury should be suspected until proven otherwise, as contrast-induced nephropathy secondary to contrast-enhanced CT or MRI imaging studies may exacerbate already present renal damage secondary to COVID-19 [84] .

Clinical and basic science research, as well as national public health guidance, regarding COVID-19 is rapidly and continuously evolving. It has been described as a novel, "once-in-a-century" disease. Along with our medicine and public health colleagues, orthopedic surgeons and orthopedic care providers should remain up to date on the latest COVID-19 peer-reviewed evidence, not only to better respond to changes in our clinical practice and to accurately counsel surgical patients but also to ultimately practice safe and efficacious surgery for patients in a new and changing clinical environment. In addition to the widely known pulmonary symptoms, COVID-19 may affect the neurologic, gastrointestinal, cardiac, and musculoskeletal systems ( Table 1) . Musculoskeletal issues remain underrecognized at this point, which may be due to the low prevalence of this disease at this time. Overall, it is imperative that all healthcare professionals have a broader understanding of all of the possible clinical and imaging manifestations of this global pandemic to improve patient and community outcomes. 

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright 

Opening Up America Again. The White House

COVID-19 digestive system involvement and clinical outcomes in a large academic hospital in

Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases

Economic impacts of the COVID-19 crisis: an orthopedic perspective

What will be the economic impact of COVID-19 in the US? Rough estimates of disease scenarios

Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT

Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms

Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview

Myositis as a manifestation of SARS-CoV-2

Covid-19 in critically ill patients in the Seattle Region: Case Series

Abdominal imaging findings in COVID-19:preliminary observations

Specific ACE2 Expression in cholangiocytes may cause liver damage after 2019-nCoV infection

Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis

The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system

Role of acute infection in triggering acute coronary syndromes

Acute pulmonary embolism and COVID-19 pneumonia: a random association?

Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses

An interactive web-based dashboard to track COVID-19 in real time

Sensitivity of Chest CT for COVID-19: comparison to RTPCR

COVID-19 and liver dysfunction: current insights and emergent therapeutic strategies

Economic effects of coronavirus outbreak (COVID-19) on the world economy. Available at SSRN 3557504

Clinical Characteristics of Covid-19 in New York City

COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 2 0 2 0

Clinical Characteristics of Coron a v i r u s D i s e a s e 2 0 1 9 i n C h i n a

Spread of SARS-CoV-2 in the Icelandic population

Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)

Digestive symptoms in covid-19 patients with mild disease severity: clinical presentation, stool viral RNA testing, and outcomes

Neurologic Features in S e v e r

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

Presentation of new onset anos

Can COVID-19 present unusual GI symptoms?

CT scans obtained for nonpulmonary indications: associated respiratory findings of COVID-19

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet

Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China

Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)

SARS-CoV-2 impact on elective orthopaedic surgery: implications for post-pandemic recovery

Rhabdomyolysis as potential late complication associated with COVID-19

Brain MRI findings in patients in the intensive care unit with COVID-19 infection

Diagnostic performance of CT and reverse transcriptasepolymerase chain reaction for coronavirus disease 2019: a meta-analysis

Viral respiratory tract infections increase platelet reactivity and activation: an explanation for the higher rates of myocardial infarction and stroke during viral illness

Acute myocardial infarction after laboratory-confirmed influenza infection

Acute pulmonary embolism in COVID-19 patients on CT angiography and relationship to D-dimer levels

The clinical and chest CT features associated with severe and critical COVID-19 pneumonia

High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in

C O V I D -1 9 . A m J E m e r g M

Pulmonary, cerebral, and renal thromboembolic disease associated with covid-19 infection [published online ahead of print

Imaging in neurological disease of hospitalized covid-19 patients: an Italian multicenter retrospective observational study

Neurologic manifestations of hospitalized patients with coronavirus disease

Zhonghua Xue Ye Xue Za Zhi

Diffuse idiopathic skeletal hyperostosis: A review

Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2

Imaging profile of the COVID-19 infection: radiologic findings and literature review

The socio-economic implications of the coronavirus pandemic (COVID-19): A review

An aging nation: the older population in the United States. United States Census Bureau, Economics and Statistics Administration

Large-vessel stroke as a presenting feature of covid-19 in the young

Time course of lung changes at chest CT during recovery from coronavirus disease

Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study

Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis

The spectrum of neurologic disease in the severe acute respiratory syndrome coronavirus 2 pandemic infection: neurologists move to the frontlines

Acute pulmonary embolism and COVID-19

Vascular changes detected with thoracic CT in coronavirus disease (COVID-19) might be significant determinants for accurate diagnosis and optimal patient management

Extremely high incidence of lower extremity deep venous thrombosis in 48 patients with severe COVID-19 in Wuhan

Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area [published online ahead of print

0 ) : 2 0 5 2 -2 0 5 9

COVID-19-Associated Leukoencephalopathy

Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 patients

Anticorps antiphospholipide, syndrome des anticorps antiphospholipides et infections virales

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study

Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China

Neuromusculoskeletal disorders following SARS: a case series

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Guillain-Barré syndrome associated with SARS-CoV-2

Mediastinal lymphadenopathy in patients with severe COVID-19

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan

The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome

A new coronavirus associated with human respiratory disease in China

Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

A rare presentation of coronavirus disease 2019 (COVID-19) induced viral myositis with subsequent rhabdomyolysis

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

COVID-19 and the cardiovascular system

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

A novel coronavirus from patients with pneumonia in China